Concepedia

Darshan G. Vaidya

DG

Statistics

Publications

8

Citations

244

H-Index

8

Active since

2000

Affiliations

Evotec (United Kingdom)(Current)

Evotec (Germany)

CHDI Foundation

Loughborough University

Evotec (United States)

Darshan G. Vaidya is an author at Evotec (United Kingdom) specializing in medicinal chemistry, drug discovery, and structure-activity relationships.

Publications per year

2000–2020

8

Publications

8

Discovery and Structure–Activity Relationship of Potent and Selective Covalent Inhibitors of Transglutaminase 2 for Huntington’s Disease

Michael E. Prime, Ole A. Andersen, John J. Barker et al. · Journal of Medicinal Chemistry · 2012 · 70 citations · Full text

, , +17

Imaging Mutant Huntingtin Aggregates: Development of a Potential PET Ligand

Longbin Liu, Michael E. Prime, Matt R. Lee et al. · Journal of Medicinal Chemistry · 2020 · 56 citations

, , +17

SAR Development of Lysine-Based Irreversible Inhibitors of Transglutaminase 2 for Huntington's Disease

John Wityak, Michael E. Prime, Frederick A. Brookfield et al. · ACS Medicinal Chemistry Letters · 2012 · 36 citations · Full text

, , +8

Stereoselective synthesis of isoquinoline derivatives from bicyclic lactam templates

Steven M. Allin, Darshan G. Vaidya, Stella L. James et al. · Tetrahedron Letters · 2002 · 26 citations

, , +15

Irreversible 4-Aminopiperidine Transglutaminase 2 Inhibitors for Huntington's Disease

Michael E. Prime, Frederick A. Brookfield, Stephen M. Courtney et al. · ACS Medicinal Chemistry Letters · 2012 · 20 citations · Full text

, , +14

1–5 of 8